A Shot to Quit Smoking?
Yes. NicVAX®, an experimental vaccine, stimulates your immune system to produce antibodies that bind to nicotine and prevent it from entering the central nervous system. Simply stated, this shot is intended to take the pleasure out of smoking.
As an example, some of our studies called for volunteers who were healthy, 18 to 65 years old, and who smoked a minimum of 10 cigarettes a day. They received 6 shots over the course of this year-ong study. Smoking cessation counseling is also provided in such studies.
A Vaccine That’s Not a Shot?
RCR has tested an experimental nasal spray vaccine against seasonal influenza that is similar to FluMist®. This brief study focused on 18-49-year-old adulst and included blood work to see if the volunteers developed antibodies against the flu.
Rochester Clinical Research performs clinical research trials and studies for pharmaceutical and biotechnology companies. We rapidly recruit and screen quality volunteers to participate in clinical studies, and we maintain a large database of volunteers. Study volunteers receive free study-related medical care, investigational medicines, and a monetary stipend to compensate for their time and travel. RCR studies include therapeutic areas and drug categories such as weight loss, diabetes, hypertension, high cholesterol, flu vaccines, and smoking cessation. Our state-of-the-art medical office facility is staffed by highly qualified, caring physicians, investigators, and nurses. RCR is located in Rochester NY and serves the Finger Lakes region of New York. RCR is a WBENC-Certified Women's Business Enterprise.
